Richeng Mao

3.0k total citations · 1 hit paper
72 papers, 2.1k citations indexed

About

Richeng Mao is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Richeng Mao has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 47 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in Richeng Mao's work include Hepatitis B Virus Studies (55 papers), Hepatitis C virus research (41 papers) and Liver Disease Diagnosis and Treatment (26 papers). Richeng Mao is often cited by papers focused on Hepatitis B Virus Studies (55 papers), Hepatitis C virus research (41 papers) and Liver Disease Diagnosis and Treatment (26 papers). Richeng Mao collaborates with scholars based in China, United States and Germany. Richeng Mao's co-authors include Jiming Zhang, Haitao Guo, Timothy M. Block, Ju‐Tao Guo, Yifei Guo, Jingjing He, Dawei Cai, Andrea Cuconati, Ran Yan and Jinyu Wang and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Richeng Mao

69 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021

2025 19 citations Richeng Mao et al. profile →

Peers

Countries citing papers authored by Richeng Mao

Since Specialization

Citations

This map shows the geographic impact of Richeng Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richeng Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richeng Mao more than expected).

Fields of papers citing papers by Richeng Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richeng Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richeng Mao. The network helps show where Richeng Mao may publish in the future.

Co-authorship network of co-authors of Richeng Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Richeng Mao. A scholar is included among the top collaborators of Richeng Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richeng Mao. Richeng Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers 2023 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), (unknown), Xiang‐Yang Ye, Hui‐Ming Lin, (unknown), Shuo Lin, (unknown), (unknown), Jiaji Jiang, (unknown), Qi Zheng, Richeng Mao, (unknown)	2
2	Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure 2023 ·Canadian Journal of Gastroenterology and Hepatology ·Yao Zhang, Xueyun Zhang, (unknown), Yifei Guo, Jingjing He, Feifei Yang, Richeng Mao, Yuxian Huang, Jiming Zhang	1
3	Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure 2023 ·Hepatology International ·Yao Zhang, Xueyun Zhang, Jiajia Han, Yifei Guo, Feifei Yang, Fahong Li, Haoxiang Zhu, Zhongliang Shen, Yuxian Huang, Richeng Mao, Jiming Zhang	7
4	Factors affecting prolonged SARS‐CoV‐2 infection and development and validation of predictive nomograms 2023 ·Journal of Medical Virology ·Yifei Guo, Yue Guo, Yongmei Zhang, Fahong Li, Jie Yu, Yao Zhang, (unknown), Richeng Mao, (unknown), (unknown)	5
5	Prevalence and Associated Factors of Low-Level Viremia in Chronic Hepatitis B Patients After Long-Term Therapy with Nucleos(t)ide Analogs 2023 ·The Turkish Journal of Gastroenterology ·Jiajia Han, Yifei Guo, Xueyun Zhang, Yao Zhang, Jian Sun, Jingjing He, Richeng Mao, Yuxian Huang, Jiming Zhang	4
6	In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study 2023 ·BMC Infectious Diseases ·Yue Guo, Yifei Guo, (unknown), (unknown), Shiqi Chen, Yao Zhang, Shenyan Zhang, (unknown), Feng Sun, Yongmei Zhang, Jie Yu, Ke Ma, Lun–Xiu Qin, Feng Long, Haoxiang Zhu, Richeng Mao, (unknown), (unknown)	4
7	Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon 2022 ·Liver International ·Yao Zhang, Jiajia Han, Xueyun Zhang, Fahong Li, Yifei Guo, Jingjing He, Richeng Mao, Haoxiang Zhu, Jie Yu, (unknown), Feifei Yang, Jiming Zhang	9
8	Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy 2022 ·Emerging Microbes & Infections ·Ning Li, Kangkang Yu, Minhui Dong, Jinyu Wang, Feifei Yang, Haoxiang Zhu, Jie Yu, (unknown), (unknown), Bidisha Mitra, Richeng Mao, Feizhen Wu, Haitao Guo, Jiming Zhang	7
9	Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines 2022 ·Emerging Microbes & Infections ·Fahong Li, Yingying Deng, Shenyan Zhang, (unknown), Jun Wang, Jinyu Wang, Xueyu Wang, Zhenyu Zhao, Wanyu Deng, Richeng Mao, Zhongliang Shen, Jieliang Chen, Ruth Broering, Yong Lin, Mengji Lu, Jiming Zhang	15
10	Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study 2022 ·Canadian Journal of Gastroenterology and Hepatology ·(unknown), Haoxiang Zhu, Yifei Guo, (unknown), Xun Qi, Feifei Yang, Richeng Mao, Jiming Zhang	1
11	A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure 2021 ·BMC Gastroenterology ·Jian Sun, Hongying Guo, Xueping Yu, Haoxiang Zhu, Xueyun Zhang, Jianghua Yang, (unknown), Zhiping Qian, Zhongliang Shen, Richeng Mao, Jiming Zhang	16
12	RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation 2021 ·Journal of Virology ·Richeng Mao, Minhui Dong, Zhongliang Shen, Hu Zhang, Yuanjie Liu, Dawei Cai, Bidisha Mitra, Jiming Zhang, Haitao Guo	23
13	Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection 2019 ·PLoS Pathogens ·Feifei Yang, Xueping Yu, Chenliang Zhou, Richeng Mao, Mengqi Zhu, Haoxiang Zhu, (unknown), Bidisha Mitra, Gan Zhao, Yuxian Huang, Haitao Guo, Bin Wang, Jiming Zhang	59
14	Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation 2019 ·Journal of Virology ·Bidisha Mitra, Jinyu Wang, Elena S. Kim, Richeng Mao, Minhui Dong, Yuanjie Liu, Jiming Zhang, Haitao Guo	55
15	Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B 2019 ·BioMed Research International ·Hongying Guo, (unknown), Shu Li, Jing Li, Zhiqing Shen, (unknown), Weidong Zhao, Dan Tan, Jingwen Wu, Xueyun Zhang, (unknown), Xun Qi, Richeng Mao, Xueping Yu, Zhijun Su, Jiming Zhang	3
16	Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients 2018 ·Liver International ·Minhui Dong, Jingwen Wu, Xueping Yu, Jing Li, Sisi Yang, Xun Qi, Richeng Mao, Yongmei Zhang, Jie Yu, Haoxiang Zhu, Feifei Yang, Yanli Qin, Jiming Zhang	35
17	Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA 2017 ·PLoS Pathogens ·Yuanjie Liu, Hui Nie, Richeng Mao, Bidisha Mitra, Dawei Cai, Ran Yan, Ju‐Tao Guo, Timothy M. Block, Nadir Mechti, Haitao Guo	103
18	Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA 2017 ·PMC ·Yuanjie Liu, Hui Nie, Richeng Mao, Bidisha Mitra, Dawei Cai, Ran Yan, Ju‐Tao Guo, Timothy M. Block, Nadir Mechti, Haitao Guo	1
19	Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China 2015 ·Hepatitis Monthly ·(unknown), Xun Qi, (unknown), Yunhao Xun, Hong Wang, Wenhong Zhang, (unknown), Jinyu Wang, Haoxiang Zhu, Richeng Mao, Jiming Zhang	11
20	A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China 2015 ·Clinical Microbiology and Infection ·Yao Zhang, Peng Hu, Xun Qi, Hong Ren, Richeng Mao, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact